Author Archives: donttradeourlivesaway

Took 400 injections, Had a Lung Removed: A TB Survivor’s Account

Source: NDTV 31 Mar 2015 (Deepti Chavan is an MDR-TB survivor and is now a spokesperson for the rights of TB patients in India.) I was 16 and appearing for my board exams when I first started feeling sick. The … Continue reading

Posted in Tuberculosis and Malaria | Leave a comment

Govt, legal experts differ on Cairn compensation demand

Source: Business Standard 30 Mar 2015 Cairn Energy Plc’s demand for compensation from India for the Rs 10,200 crore tax notice slapped on Cairn India earlier this month under the ambit of the India-UK Bilateral Investment Promotion and Protection Agreement … Continue reading

Posted in BITS, investor state dispute | Leave a comment

Indian drug companies once saved millions by producing cheap medicines – but no more

Source: Scroll 30 March 2015 Instead of making cheaper generic versions, pharmaceutical companies are being lured by voluntary licensing agreements. Between life and death often there is a patent. For Gerald Coelho, suffering from liver cancer caused by chronic Hepatitis … Continue reading

Posted in access to medicines, Hepatitis - C, patent, Voluntary License | Leave a comment

Should All Drugs Be Patentable? A Comparative Perspective

Source: Infojustice Abstract: Although there has been substantial discussion of the proper scope of patentable subject matter in recent years, drugs have been overlooked. This Article begins to address that gap with a comparative perspective. In particular, this Article considers … Continue reading

Posted in patent | Leave a comment

Pharma accused of restricting access to hep C drug in poor countries

Source: The Guardian 20 Mar 2015 New drugs for hepatitis C are a major breakthrough but hugely expensive in rich countries. Pharma giant Gilead will allow cheap copies to be made for poor countries – but only for patients with … Continue reading

Posted in Hepatitis - C, Sofosbuvir | Leave a comment

Gilead is Criticized for Restrictions on Generic Hepatitis C Drug Deal

Source: The Wall Street Journal 20 March 2015  In yet another fracas over Gilead Sciences and its hepatitis C treatments, Doctors Without Borders is harshly criticizing the drug maker over an agreement in which several generic companies will sell lower-cost … Continue reading

Posted in access to medicines, Drug regulation, Hepatitis - C, Sofosbuvir | Leave a comment


Source: KEI Europe 19 Mar 2015 Geneva, Switzerland 18 March 2015. On 10 March 2015, Knowledge Ecology International Europe (KEI Europe), in collaboration with affiliate Knowledge Ecology International (KEI), submitted a request to Romanian Minister of Health, Nicolae Banicioiu, to … Continue reading

Posted in Compulsory Licensing, Generic drug, Hepatitis - C | Leave a comment